Rephonic
Artwork for BiotechTV

BiotechTV - News

BiotechTV
Orexin
FDA
Narcolepsy
Takeda
Alkermes
Biogen
Alnylam
Biotechnology
Biotech Sector
Cedar
Pfizer
Xenon
Stoke
China
Clinical Trials
RNA Interference
AI In Biotech
Duchenne Muscular Dystrophy
Axsome Therapeutics
Peanut Allergy

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

PublishesDailyEpisodes315Founded9 months ago
Number of ListenersCategories
ScienceLife Sciences

Listen to this Podcast

Artwork for BiotechTV

Latest Episodes

The data has been accepted for an oral presentation on Monday, December 8 and will be followed by a company webcast with more info.

He describes getting through the last few years and how he thinks about 2026. Plus, comments on Xenon, Madrigal, and Alkermes.

He discusses the rationale behind the firm's asset-centric approach and highlights Vicebio as an example of how it works. Plus, his take on the current investment environment.

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Recent Guests

Ken Galbraith
Chief Executive of Zymeworks
Zymeworks
Episode: Jefferies London: Zymeworks had double-news during London Life Science Week - a P3 success for its HER2 bispecific in gastroesophageal cancer and it also launched a new royalty model
John Olyer
Founder, Chairman and CEO of BeOne Medicines
BeOne Medicines
Episode: Jefferies London: BeOne Medicines announced a phase 3 success for its HER2 bispecific today in gastric cancer. John Olyer walks us through that and the whole pipeline
Chris Roop
Head of M&A for the Americas and joint head of Global Biopharma at Jefferies
Jefferies
Episode: Jefferies London: Jefferies M&A Banker Chris Roop shares his take on the environment for deals in biotech
Ying Huang
CEO of Legend Biotech
Legend Biotech
Episode: Legend Biotech CEO Ying Huang shares a post-earnings update from the company's new R&D Center in Philadelphia
Ahmed Mousa
CEO of Vicore Pharma
Vicore Pharma
Episode: Vicore Pharma is leveraging in understanding the Renin-Angiotensin System (RAS) to develop angiotensin II type 2 receptor agonists for IPF and beyond
Unnamed Speaker
CEO of Adaptyx
Adaptyx
Episode: Adaptyx announced $14M in additional seed financing to fund the development of a continuous health monitoring device that aims to track small molecules, electrolytes, hormones, drugs, and proteins
Eran Ophir
New CEO of Compugen
Compugen
Episode: Compugen is standing firm on its belief that TIGIT will ultimately succeed with Fc reduced/silent constructs
Zhen Su
CEO of Marengo Therapeutics
Marengo Therapeutics
Episode: Marengo Therapeutics has presented data at ESMO and SITC showing that its lead program, which is designed to activate Vβ6/10 T cells, is active in multiple tumor types
Natalie Ricciardi
Senior analyst at InThought Research and expert in brain shuttle technologies.
InThought Research
Episode: Brain shuttle technologies have been in the news a lot lately. Natalie Ricciardi explains what you need to know about 1st and 2nd generation technologies in development.

Hosts

Brad
Host discussing biotech news and developments, with extensive experience in reporting within the biotech industry.
Amy
Host of BiotechTV's coverage, providing insightful commentary on biotech advancements.
Kendalle Burlin O'Connell
President and CEO of MassBio, sharing insights and perspectives on the biotech sector.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Jefferies London: Sofinnova Partners announced a new $750M fund XI today that will invest in early stage companies in biotech
Q: What interests you today in investing? Is there any area of our sector that is particularly exciting to you?
Antoine Papiernik expressed interest in various sectors like oncology, cardiometabolic diseases, and the growing relevance of AI in enhancing healthcare investments.
Jefferies London: Chief Scientific Officer Tony Wood covers the latest highlights in GSK's pipeline, including oncology, respiratory, and inflammation
Q: What are your expectations as Luke Mield transitions into his new role as CEO?
Tony Wood expresses confidence in the transition to Luke Mield and emphasizes continuity and building on the progress made in R&D.
Jefferies London: Chief Scientific Officer Tony Wood covers the latest highlights in GSK's pipeline, including oncology, respiratory, and inflammation
Q: What attracted you about FGF21, especially given the competition in the market?
Tony Wood details GSK's focus on FGF21 due to its promising efficacy in treating fibrosis and cirrhosis, highlighting its longer half-life and lower immunogenicity.
Jefferies London: Olema Oncology more than doubled yesterday when Roche announced surprise data for its oral SERD - the CEO reacts and shares the development program for Olema's competing asset
Q: Can you tell us about your ongoing Phase 3 trial?
The trial is focused on palazestrin, aiming to show better progression-free survival compared to existing treatments for breast cancer.
Jefferies London: Olema Oncology more than doubled yesterday when Roche announced surprise data for its oral SERD - the CEO reacts and shares the development program for Olema's competing asset
Q: What was the news yesterday and what was your take?
Roche announced positive results of a trial called Lidera, which showed improvement in disease-free survival with their drug gerodestrin in breast cancer patients.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About BiotechTV

What is BiotechTV about and what kind of topics does it cover?

Content revolves around developments in the biotechnology sector, including insights on clinical trials, groundbreaking therapies, and innovations related to drug development. Episodes frequently feature interviews with industry leaders discussing their companies' latest products and scientific advancements. The emphasis on practical applications and real-world implications of biotech innovations aims to provide listeners with a comprehensive understanding of ongoing changes and opportunities within the life sciences landscape. Unique elements include on-site reporting from key biotech events and conferences, allowing for timely and relevant coverage of industry trends.

Where can I find podcast stats for BiotechTV?

Rephonic provides a wide range of podcast stats for BiotechTV. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to BiotechTV and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does BiotechTV get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for BiotechTV, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for BiotechTV?

Rephonic provides comprehensive predictive audience data for BiotechTV, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does BiotechTV have?

To see how many followers or subscribers BiotechTV has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to BiotechTV?

These podcasts share a similar audience with BiotechTV:

1. Biotech Hangout
2. The Long Run with Luke Timmerman
3. BioCentury This Week
4. The Readout Loud
5. Biotech 2050 Podcast

How many episodes of BiotechTV are there?

BiotechTV launched 9 months ago and published 315 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact BiotechTV?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for BiotechTV?

Rephonic pulls ratings and reviews for BiotechTV from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for BiotechTV?

Rephonic provides full transcripts for episodes of BiotechTV. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on BiotechTV?

Recent guests on BiotechTV include:

1. Ken Galbraith
2. John Olyer
3. Chris Roop
4. Ying Huang
5. Ahmed Mousa
6. Unnamed Speaker
7. Eran Ophir
8. Zhen Su

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days